Clinical Trial Update: LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG [NA]

View source ↗

Summary

Clinical trial update describing a study investigating whether liquid biopsy can predict responses to first-line immunotherapy in metastatic non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut Curie | Conditions: Metastatic Lung Cancer | NA | Status: RECRUITING